Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1681 AL 1695

Pongamol as a multitarget neuroprotective candidate: an integrative analysis of in silico predictions and biological evidence

Preeti, Akanksha, Khurana N.

Nat Prod Res. 2026 Jul 1:1-14. doi: 10.1080/14786419.2026.2694726. Online ahead of print.

From clinical phenotypes to molecular stratification: early differential diagnosis of four-repeat tauopathies

Bernhardt AM, Höglinger GU, Palleis C.

Front Aging Neurosci. 2026 Jun 16;18:1801615. doi: 10.3389/fnagi.2026.1801615. eCollection 2026.

EYE movement abnormalities in Parkinson's disease: optometric screening and rehabilitation

Yadav R, Rastogi D, Kumar S, Chowdhury P, Austin E.

Clin Park Relat Disord. 2026 Jun 18;15:100468. doi: 10.1016/j.prdoa.2026.100468. eCollection 2026.

Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease

Urban V, Schreieder L, Drexler K, Weise D, Haferkamp S.

J Dtsch Dermatol Ges. 2026 Jul 1. doi: 10.1111/ddg.70317x. Online ahead of print.

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study

Tohge R, Kaneko S, Kouda K, Oki M, Asayama S, Hatsuta H, Wate R, Yakushiji Y.

Clin Neuropharmacol. 2026 Jul-Aug 01;49(4):155-160. doi: 10.1097/WNF.0000000000000686. Epub 2026 Apr 17.

Neurobiological after-effects and clinical efficacy of transcranial magnetic stimulation (TMS) in Parkinson's disease: a systematic review

Buonocore A, Vermiglio G, Citro S, Cafaro C, De Luca C, Di Cecca A, Sepe G, Marcello L, Soricelli A, Cavaliere C, Cirillo G.

Brain Struct Funct. 2026 Jul 1;231(6):94. doi: 10.1007/s00429-026-03150-4.

Self-management in neurological disorders: a scoping review of behavior change theories, strategies, contents, and impact

Joseph C, Balogun OJ, Kasser S, Escorpizo R.

Disabil Rehabil. 2026 Jul 1:1-21. doi: 10.1080/09638288.2026.2694102. Online ahead of print.

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease

LeDoux MS.

Neurology. 2026 Jul 28;107(2):e218370. doi: 10.1212/WNL.0000000000218370. Epub 2026 Jul 1.

Urodynamics and what they reveal about autonomic innervation of the lower urinary tract: A narrative review

Yasmin H, Aleksejeva K, Johnston L, Malladi P, Simeoni S, Pakzad M.

Auton Neurosci. 2026 Aug;266:103452. doi: 10.1016/j.autneu.2026.103452. Epub 2026 Jun 23.

Respiratory-swallow training in Parkinson's disease: Effects of a single session on swallowing safety and efficiency with exploratory comparisons of biofeedback

Curtis JA, Lowell ER, Troche MS.

Parkinsonism Relat Disord. 2026 Aug;149:108407. doi: 10.1016/j.parkreldis.2026.108407. Epub 2026 Jun 28.

Serious games and virtual reality in Parkinson's disease rehabilitation: A systematic review of randomized controlled trials

Silva E, Rocha D, Naves E.

Parkinsonism Relat Disord. 2026 Aug;149:108408. doi: 10.1016/j.parkreldis.2026.108408. Epub 2026 Jun 30.

Clinical response after cerebrospinal fluid shunting in complex versus pure idiopathic normal pressure hydrocephalus: A systematic review and meta-analysis

Arruda Maciel C, Oliveira da Silva KG, Galbim de Paula V, Alves Santana V, Teles de Menezes MCJ, Campos Gomes Pinto F.

Clin Neurol Neurosurg. 2026 Oct;269:109557. doi: 10.1016/j.clineuro.2026.109557. Epub 2026 Jun 25.

Peripheral nervous system involvement in Parkinson's disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications

Qian J, Wang H, Zhang Y, Cui J, Cao Y, Xie J, Shi L.

Neurosci Biobehav Rev. 2026 Sep;188:106840. doi: 10.1016/j.neubiorev.2026.106840. Epub 2026 Jul 1.

Amylin at the crossroads of type 2 diabetes and neurodegenerative diseases

López Del Castillo I, Garcia-Martin J, Gutierrez A, Moreno-Gonzalez I.

Ageing Res Rev. 2026 Oct;121:103226. doi: 10.1016/j.arr.2026.103226. Epub 2026 Jul 1.

α-Synuclein aggregation landscape from phase separation to neurotoxic intermediates

Arino S, Fusco G, De Simone A.

FEBS Lett. 2026 Jul;600(14):1955-1965. doi: 10.1002/1873-3468.70393. Epub 2026 Jul 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias